These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23228321)

  • 1. Safety and efficacy of bridging with low molecular weight heparins: a systematic review and partial meta-analysis.
    Eijgenraam P; ten Cate H; Ten Cate-Hoek A
    Curr Pharm Des; 2013; 19(22):4014-23. PubMed ID: 23228321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy.
    Spyropoulos AC; Bauersachs RM; Omran H; Cohen M
    Curr Med Res Opin; 2006 Jun; 22(6):1109-22. PubMed ID: 16846544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.
    Siegal D; Yudin J; Kaatz S; Douketis JD; Lim W; Spyropoulos AC
    Circulation; 2012 Sep; 126(13):1630-9. PubMed ID: 22912386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Barba M; Rohilla S; Terrenato I; Sperati F; Muti P; Schünemann HJ
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006650. PubMed ID: 18425959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
    Shah S; Nayfeh T; Hasan B; Urtecho M; Firwana M; Saadi S; Abd-Rabu R; Nanaa A; Flynn DN; Rajjoub NS; Hazem W; Seisa MO; Hassett LC; Spyropoulos AC; Douketis JD; Murad MH
    Chest; 2023 May; 163(5):1245-1257. PubMed ID: 36462533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
    Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S
    Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.
    Baumgartner C; de Kouchkovsky I; Whitaker E; Fang MC
    Am J Med; 2019 Jun; 132(6):722-732.e7. PubMed ID: 30659809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
    van Der Heijden JF ; Hutten BA; Büller HR; Prins MH
    Cochrane Database Syst Rev; 2000; (4):CD002001. PubMed ID: 11034739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin.
    Malato A; Saccullo G; Lo Coco L; Caramazza D; Abbene I; Pizzo G; Casuccio A; Siragusa S
    J Thromb Haemost; 2010 Jan; 8(1):107-13. PubMed ID: 19817996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.
    Akl EA; Karmath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook D; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006468. PubMed ID: 17636845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative Management in Patients Using Vitamin K Antagonists: Observational Cohort Study.
    Burggraaf JLI; van Rein N; van der Meer FJM; Lijfering WM
    Thromb Haemost; 2020 Mar; 120(3):495-504. PubMed ID: 31940676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging anticoagulation in patients treated with vitamin K antagonists prior to trochanteric and hip fracture surgeries: The current practice.
    Szklanny K; Jakubek M; Zbierska-Rubinkiewicz K; Undas A
    Adv Clin Exp Med; 2019 Apr; 28(4):469-477. PubMed ID: 30088350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
    van der Heijden JF; Hutten BA; Büller HR; Prins MH
    Cochrane Database Syst Rev; 2002; (1):CD002001. PubMed ID: 11869618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update in bridging anticoagulation.
    Kaatz S; Paje D
    J Thromb Thrombolysis; 2011 Apr; 31(3):259-64. PubMed ID: 21327504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.
    Schulman S; Healey JS; Douketis JD; Delaney J; Morillo CA
    Thromb Res; 2014 Oct; 134(4):814-8. PubMed ID: 25127655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bridging anticoagulation].
    Schellong SM; Halbritter K; Haas S
    Chirurg; 2007 Feb; 78(2):125-6, 128-32. PubMed ID: 17252252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low- molecular- weight- heparin versus vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: a systematic review of randomized controlled trials.
    Louzada ML; Majeed H; Wells PS
    Thromb Res; 2009 Apr; 123(6):837-44. PubMed ID: 18977517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.